The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Circulating Exosomal MicroRNA-21 as a Biomarker in Each Tumor Stage of Colorectal Cancer
Open accessAbstract
Objective: We clarified the predictive and prognostic value of circulating plasma exosomal microRNA-21 (miR-21) in each TNM stage of colorectal cancer (CRC) patients. Methods: The microRNA (miRNA) profiles of the plasma exosomes, primary tumor tissues, and liver metastasis tissues from the same CRC patients were examined using a microarray. For validation analysis, the plasma exosome samples from 326 CRC patients were measured by TaqMan miRNA assays. Results: In the miRNA microarray analyses, miR-21 showed the highest upregulation in exosomes, primary tumor tissues, and liver metastasis tissues. Significant correlations were demonstrated between exosomal miR-21 and tissue miR-21 levels. As for the relationship to the pathological condition, exosomal miR-21 showed a significant association with liver metastasis and TNM stage. The overall survival (OS) rates and disease-free survival (DFS) rates in high-exosomal-miR-21 patients were significantly worse than those in low-miR-21 patients. Exosomal miR-21 levels were an independent prognostic factor for OS and DFS in CRC patients with TNM stage II or III, and for OS in patients with TNM stage IV. Conclusion: Plasma exosomal miR-21 levels are a useful biomarker for the prediction of recurrence and poor prognosis in CRC patients with TNM stage II, III, or IV.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Moreover, miR-21 has been demonstrated to be packaged within exosomes and released from different cancer types (51–54).”
From Potential Therapeutic Effects of Exosomes Packed With a miR-21-Sponge Construct in a Rat Model of Glioblastoma (2019) · cites this paper as [53]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R., Ma, J., Zou, Z., & Jemal, A. (2014) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21208 · Cited by 11,499
Chen, X., Ba, Y., Ma, L., Cai, X., Yin, Y., Wang, K., Guo, J., Zhang, Y., Chen, J., Guo, X., et al. (2008) · Cell Research · doi:10.1038/cr.2008.282 · Cited by 4,560
Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET
Peinado, H., Alečković, M., Lavotshkin, S., Matei, I., Costa-Silva, B., Moreno-Bueno, G., Hergueta-Redondo, M., Williams, C., García-Santos, G., Ghajar, C. M., et al. (2012) · Nature Medicine · doi:10.1038/nm.2753 · Cited by 3,715
Japanese Society for Cancer of the Colon and Rectum, Watanabe, T., Muro, K., Ajioka, Y., Hashiguchi, Y., Ito, Y., Saito, Y., Hamaguchi, T., Ishida, H., Ishiguro, M., et al. (2018) · International Journal of Clinical Oncology · doi:10.1007/s10147-017-1101-6 · Cited by 2,467
Self-citationExosomes – vesicular carriers for intercellular communication
Simons, M., & Raposo, G. (2009) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.03.007 · Cited by 2,410
Biogenesis and secretion of exosomes
Kowal, J., Tkach, M., & Théry, C. (2014) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2014.05.004 · Cited by 1,781
Watanabe, T., Itabashi, M., Shimada, Y., Tanaka, S., Ito, Y., Ajioka, Y., Hamaguchi, T., Hyodo, I., Igarashi, M., Ishida, H., et al. (2015) · International Journal of Clinical Oncology · doi:10.1007/s10147-015-0801-z · Cited by 596
Intercellular Communication by Exosome-Derived microRNAs in Cancer
Hannafon, B. N., & Ding, W. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140714240 · Cited by 537
Serum miR-21 as a Diagnostic and Prognostic Biomarker in Colorectal Cancer
Toiyama, Y., Takahashi, M., Hur, K., Nagasaka, T., Tanaka, K., Inoue, Y., Kusunoki, M., Boland, C. R., & Goel, A. (2013) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt101 · Cited by 504
miRNA in Plasma Exosome is Stable under Different Storage Conditions
Ge, Q., Zhou, Y., Lu, J., Bai, Y., Xie, X., & Lu, Z. (2014) · Molecules · doi:10.3390/molecules19021568 · Cited by 482
Flagged first, then by citations
Research works printed but not linked: 1
- 10.1093/carcin/bgu189 · DOI
Cited by
Sorted by citations
miRNAs as Biomarkers in Disease: Latest Findings Regarding Their Role in Diagnosis and Prognosis
Condrat, C. E., Thompson, D. C., Barbu, M. G., Bugnar, O. L., Boboc, A. E., Crețoiu, D., Suciu, N., Creţoiu, S. M., & Voinea, S. C. (2020) · Cells · doi:10.3390/cells9020276 · Cited by 1,399
Liquid biopsy in cancer: current status, challenges and future prospects
Ma, L., Guo, H., Zhao, Y., Liu, Z., Wang, C., Bu, J., Sun, T., & Wei, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02021-w · Cited by 820
Breast milk, a source of beneficial microbes and associated benefits for infant health
Lyons, K. E., Ryan, C. A., Dempsey, E. M., Ross, R. P., & Stanton, C. (2020) · Nutrients · doi:10.3390/nu12041039 · Cited by 613
Circulating microRNAs as potential cancer biomarkers: the advantage and disadvantage
Wang, H., Peng, R., Wang, J., Qin, Z., & Xue, L. (2018) · Clinical Epigenetics · doi:10.1186/s13148-018-0492-1 · Cited by 540
Clinical utility of circulating non-coding RNAs — an update
Anfossi, S., Babayan, A., Pantel, K., & Călin, G. A. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0035-x · Cited by 464
Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samples
Russano, M., Napolitano, A., Ribelli, G., Iuliani, M., Simonetti, S., Citarella, F., Pantano, F., Dell’Aquila, E., Anesi, C., Silvestris, N., et al. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01601-2 · Cited by 267
Noncoding RNAs in Extracellular Fluids as Cancer Biomarkers: The New Frontier of Liquid Biopsies
Pardini, B., Sabo, A. A., Birolo, G., & Calin, G. A. (2019) · Cancers · doi:10.3390/cancers11081170 · Cited by 204
Exosomes as potential sources of biomarkers in colorectal cancer
Xiao, Y., Zhong, J., Zhong, B., Huang, J., Jiang, L., Jiang, Y., Yuan, J., Sun, J. G., Dai, L., Yang, C., et al. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.01.033 · Cited by 186
Exosomal miR-21 regulates the TETs/PTENp1/PTEN pathway to promote hepatocellular carcinoma growth
Cao, L., Yang, X., Chen, Y., Zhang, D., Jiang, X., & Xue, P. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1075-2 · Cited by 185
Circulating microRNAs as biomarkers in cancer diagnosis
Sohel, M. M. H. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117473 · Cited by 168
Cancer-secreted exosomal miR-21-5p induces angiogenesis and vascular permeability by targeting KRIT1
He, Q., Ye, A., Ye, W., Liao, X., Qin, G.-Q., Xu, Y., Yin, Y., Luo, H., Yi, M., Xian, L., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03803-8 · Cited by 165
MicroRNA-193b-3p regulates chondrogenesis and chondrocyte metabolism by targeting HDAC3
Meng, F., Li, Z., Zhang, Z., Yang, Z., Kang, Y. Q., Zhao, X., Long, D., Hu, S., Gu, M., He, S., et al. (2018) · Theranostics · doi:10.7150/thno.23547 · Cited by 156
Emerging microRNA biomarkers for colorectal cancer diagnosis and prognosis
Chen, B., Xia, Z., Deng, Y., Yang, Y., Zhang, P., Zhu, H., Xu, N., & Liang, S. (2019) · Open Biology · doi:10.1098/rsob.180212 · Cited by 156
Dynamic liquid biopsy components as predictive and prognostic biomarkers in colorectal cancer
Raza, A., Khan, A. Q., Inchakalody, V. P., Mestiri, S., Yoosuf, Z. S. K. M., Bedhiafi, T., El-Ella, D. M. A., Taib, N., Hydrose, S., Akbar, S., et al. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02318-0 · Cited by 160
Liu, X., Pan, B., Sun, L., Chen, X., Zeng, K., Hu, X., Xu, T., Xu, M., & Wang, S. (2018) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-18-0067 · Cited by 137
Extracellular vesicles and particles impact the systemic landscape of cancer
Lucotti, S., Kenific, C. M., Zhang, H., & Lyden, D. C. (2022) · The EMBO Journal · doi:10.15252/embj.2021109288 · Cited by 145
Sabry, D., El-Deek, S. E. M., Maher, M., El-Baz, M. A. H., El-Bader, H. M., Amer, E., Hassan, E. A., Fathy, W., & El-Deek, H. E. M. (2018) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-018-3462-1 · Cited by 135
Takahasi, K., Iinuma, H., Wada, K., 俊亮, 峯., Kawamura, S., Kainuma, M., Ikeda, Y., Shibuya, M., Miura, F., & Sano, K. (2017) · Journal of Hepato-Biliary-Pancreatic Sciences · doi:10.1002/jhbp.524 · Cited by 132
Self-citationMonfared, H., Jahangard, Y., Nikkhah, M., Mirnajafi-Zadeh, J., & Mowla, S. J. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00782 · Cited by 123
de Miguel‐Pérez, D., Martínez, A. R., Palomo, A. O., Ureña, M. D., Puche, J. L. G., Robles-Remacho, A., Hernández, J. E., Lorente, J. A., Ortega, F. G., & Serrano, M. J. (2020) · Scientific Reports · doi:10.1038/s41598-020-60212-1 · Cited by 131
Advanced Nanotechnologies for Extracellular Vesicle‐Based Liquid Biopsy
Min, L., Wang, B., Bao, H., Li, X., Zhao, L., Meng, J., & Wang, S. (2021) · Advanced Science · doi:10.1002/advs.202102789 · Cited by 120
Extracellular Vesicles: Mechanisms in Human Health and Disease
Malloci, M., Perdomo, L., Veerasamy, M., Andriantsitohaina, R., Simard, G., & Martínez, M. C. (2018) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7265 · Cited by 131
The dawn of the liquid biopsy in the fight against cancer
Domínguez-Vigil, I. G., Moreno-Martínez, A. K., Wang, J. Y., Roehrl, M. H. A., & Barrera-Saldaña, H. A. (2017) · Oncotarget · doi:10.18632/oncotarget.23131 · Cited by 121
Shao, C., Yang, F., Qin, Z., Jing, X., Shu, Y., & Shen, H. (2019) · BMC Cancer · doi:10.1186/s12885-019-6297-6 · Cited by 114
Yoshikawa, M., Iinuma, H., 靖子, 梅., Yanagisawa, T., Matsumoto, A., & Jinno, H. (2018) · Oncology Letters · doi:10.3892/ol.2018.8457 · Cited by 109
Self-citationExosomal Non Coding RNA in LIQUID Biopsies as a Promising Biomarker for Colorectal Cancer
Baassiri, A., Nassar, F. J., Mukherji, D., Shamseddine, A. I., Nasr, R., & Temraz, S. N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041398 · Cited by 110
Kawamura, S., Iinuma, H., Wada, K., Takahashi, K., 俊亮, 峯., Kainuma, M., Shibuya, M., Miura, F., & Sano, K. (2018) · Journal of Hepato-Biliary-Pancreatic Sciences · doi:10.1002/jhbp.601 · Cited by 101
Self-citationClinical significance of exosomes as potential biomarkers in cancer
Wong, C. H., & Chen, Y. (2019) · World Journal of Clinical Cases · doi:10.12998/wjcc.v7.i2.171 · Cited by 98
Jin, Y., Wang, M., Hu, H., Huang, Q., Chen, Y., & Wang, G. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.05.151 · Cited by 91
Tumor‐derived exosomal miRNA‐320d as a biomarker for metastatic colorectal cancer
Tang, Y., Zhao, Y., Song, X., Song, X., Niu, L., & Xie, L. (2019) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.23004 · Cited by 87
Circulating microRNAs as Promising Biomarkers in Colorectal Cancer
Rapado‐González, Ó., Álvarez-Castro, A., López‐López, R., Iglesias-Canle, J., Suárez‐Cunqueiro, M. M., & Muinelo‐Romay, L. (2019) · Cancers · doi:10.3390/cancers11070898 · Cited by 85
The pre-analytical phase of the liquid biopsy
Salvianti, F., Gelmini, S., Costanza, F., Mancini, I., Sonnati, G., Simi, L., Pazzagli, M., & Pinzani, P. (2019) · New Biotechnology · doi:10.1016/j.nbt.2019.09.006 · Cited by 86
Elrebehy, M. A., Al-Saeed, S., Gamal, S., El‐Sayed, A., Ahmed, A. A., Waheed, O., Ismail, A., El‐Mahdy, H. A., Sallam, A.-A. M., & Doghish, A. S. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.06.134 · Cited by 83
Kumata, Y., Iinuma, H., Suzuki, Y., Tsukahara, D., Midorikawa, H., Igarashi, Y., Soeda, N., Kiyokawa, T., Horikawa, M., & Fukushima, R. (2018) · Oncology Reports · doi:10.3892/or.2018.6418 · Cited by 79
Self-citationExosome-mediated miR-200b promotes colorectal cancer proliferation upon TGF-β1 exposure
Zhang, Z., Xing, T., Chen, Y., & Xiao, J. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.07.042 · Cited by 77
The Role of microRNA-21 in the Onset and Progression of Cancer
Singh, A. K., Singh, A. K., Giri, R., Kumar, D., Sharma, R., Vališ, M., Kuča, K., & Garg, N. (2021) · Future Medicinal Chemistry · doi:10.4155/fmc-2021-0096 · Cited by 81
The Liquid Biopsy in the Management of Colorectal Cancer: An Overview
Vacante, M., Ciuni, R., Basile, F., & Biondi, A. (2020) · Biomedicines · doi:10.3390/biomedicines8090308 · Cited by 75
Exosomes and their importance in metastasis, diagnosis, and therapy of colorectal cancer
Cheshomi, H., & Matin, M. M. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27582 · Cited by 74
Qian, K., Fu, W., Li, T., Zhao, J., Lei, C., & Hu, S. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02492-1 · Cited by 72
Exosomes: A Source for New and Old Biomarkers in Cancer
Logozzi, M., Mizzoni, D., Raimo, R. D., & Fais, S. (2020) · Cancers · doi:10.3390/cancers12092566 · Cited by 69
Yan, S., Liu, G., Jin, C., Wang, Z., Duan, Q., Jiang, X., & Xu, D. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.26316 · Cited by 67
RetractedMiR-21-5p Induces Pyroptosis in Colorectal Cancer via TGFBI
Jiang, R., Chen, X., Ge, S., Wang, Q., Liu, Y., Chen, H., Xu, J., & Wu, J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.610545 · Cited by 66
Circulating miRNA as Biomarkers for Colorectal Cancer Diagnosis and Liver Metastasis
Nassar, F. J., Msheik, Z. S., Itani, M. M., Helou, R. E., Hadla, R., Kreidieh, F., Bejjany, R., Mukherji, D., Shamseddine, A. I., Nasr, R., et al. (2021) · Diagnostics · doi:10.3390/diagnostics11020341 · Cited by 64
Feng, C., Zhang, L., Sun, Y., Li, X., Zhan, L., Lou, Y. J., Wang, Y., Liu, L., & Zhang, Y. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.03.028 · Cited by 64
Relevance of MicroRNAs as Potential Diagnostic and Prognostic Markers in Colorectal Cancer
Hibner, G., Kimsa-Furdzik, M., & Francuz, T. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19102944 · Cited by 63
Pu, C., Huang, H., Wang, Z., Zou, W., Lv, Y., Zhou, Z., Zhang, Q., Qiao, L., Wu, F., & Shao, S. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00930 · Cited by 58
Ragusa, M., Barbagallo, C., Cirnigliaro, M., Battaglia, R., Brex, D., Caponnetto, A., Barbagallo, D., Pietro, C. D., & Purrello, M. (2017) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2017.00066 · Cited by 56
Mjelle, R., Dima, S., Bacalbașa, N., Chawla, K., Sorop, A., Cucu, D., Herlea, V., Sætrom, P., & Popescu, I. (2019) · BMC Cancer · doi:10.1186/s12885-019-6249-1 · Cited by 58
Liu, S.-Y., Liao, Y., Hosseinifard, H., İmani, S., & Wen, Q. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.705791 · Cited by 53
Salmond, N., & Williams, K. C. (2021) · Nanoscale Advances · doi:10.1039/d0na00676a · Cited by 57
Madhyastha, R., Madhyastha, H., Nurrahmah, Q. I., Purbasari, B., Maruyama, M., & Nakajima, Y. (2021) · Inflammation · doi:10.1007/s10753-021-01415-0 · Cited by 53
Exosomes as emerging players in cancer biology
Couto, N., Caja, S., Maia, J., Moraes, M. C. S., & Costa‐Silva, B. (2018) · Biochimie · doi:10.1016/j.biochi.2018.03.006 · Cited by 52
Molecular functions and therapeutic applications of exosomal noncoding RNAs in cancer
Liu, Q., He, Y., & Xu, W. (2022) · Experimental & Molecular Medicine · doi:10.1038/s12276-022-00744-w · Cited by 50
Biological Implications and Clinical Potential of Metastasis-Related miRNA in Colorectal Cancer
Niu, L., Yang, W., Duan, L., Wang, X., Li, Y., Xu, C., Liu, C., Zhang, Y., Zhou, W. J., Liu, J., et al. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.10.030 · Cited by 50
The plasma exosomal miR-1180-3p serves as a novel potential diagnostic marker for cutaneous melanoma
Guo, Y., Zhang, X., Wang, L., Li, M., Shen, M., Zhou, Z., Zhu, S., Li, K., Fang, Z., Yan, B., et al. (2021) · Cancer Cell International · doi:10.1186/s12935-021-02164-8 · Cited by 50
A panel of three plasma microRNAs for colorectal cancer diagnosis
Tan, Y., Lin, J.-J., Yang, X., Gou, D.-M., Fu, L., Li, F.-R., & Yu, X.-F. (2019) · Cancer Epidemiology · doi:10.1016/j.canep.2019.01.015 · Cited by 49
Exosomal microRNAs and other non-coding RNAs as colorectal cancer biomarkers: a review
Francavilla, A., Turoczi, S., Tarallo, S., Vodička, P., Pardini, B., & Naccarati, A. (2019) · Mutagenesis · doi:10.1093/mutage/gez038 · Cited by 46
Yamana, K., Inoue, J., Yoshida, R., Sakata, J., Nakashima, H., Arita, H., Kawaguchi, S., Gohara, S., Nagao, Y., Takeshita, H., et al. (2021) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12169 · Cited by 45
Circulating exosomal miRNAs: clinical significance in human cancers
Avgeris, M., Panoutsopoulou, K., Papadimitriou, M., & Scorilas, A. (2019) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2019.1673732 · Cited by 45
Yang, W., Wang, H., Wang, W.-D., Bai, P., Lu, H., Sun, C., Liu, Z., Guan, D., Yang, G., & Zhang, G. (2019) · Cancer Medicine · doi:10.1002/cam4.2642 · Cited by 42
Exosomal miRNA: Small Molecules, Big Impact in Colorectal Cancer
Vautrot, V., Chanteloup, G., Elmallah, M. I. Y., Cordonnier, M., Aubin, F., Garrido, C., & Gobbo, J. (2019) · Journal of Oncology · doi:10.1155/2019/8585276 · Cited by 43
Circulating Exosomal miRNAs as Biomarkers for the Diagnosis and Prognosis of Colorectal Cancer
dos Santos, K. A., dos Santos, I. C. C., Silva, C. S., Ribeiro, H. G., Domingos, I. F., & Silbiger, V. N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010346 · Cited by 42
Merhi, M., Ahmad, F., Taib, N., Inchakalody, V. P., Shahab Uddin, M. S., Shablak, A., & Dermime, S. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.01.001 · Cited by 41
Implications and pitfalls for cancer diagnostics exploiting extracellular vesicles
Špilak, A., Brachner, A., Kegler, U., Neuhaus, W., & Noehammer, C. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.05.029 · Cited by 41
Yagi, T., Iinuma, H., Hayama, T., Matsuda, K., Nozawa, K., Tsukamoto, M., Shimada, R., Akahane, T., Tsuchiya, T., Ozawa, T., et al. (2019) · Molecular and Clinical Oncology · doi:10.3892/mco.2019.1911 · Cited by 40
Self-citationQu, J., Yang, J., Chen, M., Cui, L., Wang, T., Gao, W., Tian, J., & Wei, R. (2019) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.35.5.685 · Cited by 40
Tumor-Derived Exosomal miR-620 as a Diagnostic Biomarker in Non-Small-Cell Lung Cancer
Tang, Y., Zhang, Z., Song, X., Yu, M., Niu, L., Zhao, Y., Wang, L., Song, X., & Xie, L. (2020) · Journal of Oncology · doi:10.1155/2020/6691211 · Cited by 39
He, J., Wu, F., Han, Z., Hu, M., Lin, W., Li, Y., & Cao, M. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.632834 · Cited by 39
Plasma Level Of miR-21 And miR-451 In Primary And Recurrent Breast Cancer Patients
Motamedi, M., Chaleshtori, M. H., Ghasemi, S., & Mokarian, F. (2019) · Breast Cancer Targets and Therapy · doi:10.2147/bctt.s224333 · Cited by 37
Tumor-derived exosomal non-coding RNAs as diagnostic biomarkers in cancer
Ebrahimi, N., Faghihkhorasani, F., Fakhr, S. S., moghaddam, P. R., Yazdani, E., Kheradmand, Z., Rezaei‐Tazangi, F., Adelian, S., Mobarak, H., Hamblin, M. R., et al. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04552-3 · Cited by 37
Heidrich, I., Abdalla, T. S. A., Reeh, M., & Pantel, K. (2021) · Cancers · doi:10.3390/cancers13184500 · Cited by 38
Exosomes in Hepatitis B Virus Transmission and Related Immune Response
Wang, J., Cao, D., & Yang, J. (2020) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.252.309 · Cited by 37
Clinical Impact of Exosomes in Colorectal Cancer Metastasis
Ghosh, S., Dhar, R., Shivji, G. G., Dey, D., Devi, A., Jha, S. K., Adhikari, M. D., & Gorai, S. (2023) · ACS Applied Bio Materials · doi:10.1021/acsabm.3c00199 · Cited by 35
Cho, W.-C., Kim, M. J., Park, J. W., Jeong, S., & Ku, J. (2020) · Translational Oncology · doi:10.1016/j.tranon.2020.101000 · Cited by 35
Soeda, N., Iinuma, H., Suzuki, Y., Tsukahara, D., Midorikawa, H., Igarashi, Y., Kumata, Y., Horikawa, M., Kiyokawa, T., Fukagawa, T., et al. (2019) · Oncology Letters · doi:10.3892/ol.2019.10807 · Cited by 34
Self-citationRoles of miRNAs in Colorectal Cancer: Therapeutic Implications and Clinical Opportunities
Mehrgou, A., Ebadollahi, S., Seidi, K., Ayoubi‐Joshaghani, M. H., Ahmadieh-Yazdi, A., Zare, P., Jaymand, M., & Jahanban‐Esfahlan, R. (2020) · Advanced Pharmaceutical Bulletin · doi:10.34172/apb.2021.029 · Cited by 33
Liquid biopsies in gastrointestinal malignancies: when is the big day?
Lopez, A., Harada, K., Kaya, D. M., Dong, X., Song, S., & Ajani, J. A. (2017) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2018.1403320 · Cited by 32
Ilkhani, K., Bastami, M., Delgir, S., Safi, A., Talebian, S., & Alivand, M. R. (2020) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520620666200910123428 · Cited by 33
Role of exosomes in pancreatic cancer (Review)
Liu, H., Qiao, S., Fan, X., Gu, Y., Zhang, Y., & Huang, S. (2021) · Oncology Letters · doi:10.3892/ol.2021.12559 · Cited by 31
Lee, E. K., Jeong, H. O., Bang, E. J., Kim, C. H., Mun, J. Y., Noh, S., Gim, J., Kim, D., Chung, K. W., Yu, B. P., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.23651 · Cited by 27
A meta-analysis on the prognosis of exosomal miRNAs in all solid tumor patients
Zhou, J., Guo, H., Yang, Y., Zhang, Y., & Liu, H. (2019) · Medicine · doi:10.1097/md.0000000000015335 · Cited by 27
Ahmadi, M., Jafari, R., Mahmoodi, M., & Rezaie, J. (2021) · Cell Biochemistry and Function · doi:10.1002/cbf.3622 · Cited by 26
Prognostic value of microRNAs in colorectal cancer: a meta-analysis
Gao, S., Zhao, Z., Wu, R., Zhang, Y., & Zhang, Z.-Y. (2018) · Cancer Management and Research · doi:10.2147/cmar.s157493 · Cited by 25
Luo, D., Huang, Z., Lv, H., Wang, Y., Sun, W., & Sun, X. (2020) · Cancer Management and Research · doi:10.2147/cmar.s221731 · Cited by 25
Diagnostic Potential of Exosomal microRNAs in Colorectal Cancer
Dohmen, J., Semaan, A., Kobilay, M., Zaleski, M., Branchi, V., Schlierf, A., Hettwer, K., Uhlig, S., Hartmann, G., Kalff, J. C., et al. (2022) · Diagnostics · doi:10.3390/diagnostics12061413 · Cited by 24
Exosomes as a Source of Biomarkers for Gastrointestinal Cancers
Yu, J., Ostowari, A., Gonda, A., Mashayekhi, K., Dayyani, F., Hughes, C. C. W., & Senthil, M. (2023) · Cancers · doi:10.3390/cancers15041263 · Cited by 23
Exosomal noncoding RNAs in colorectal cancer
Wu, Q., Liu, W., Wang, J., Zhu, L., Wang, Z., & Peng, Y. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.08.037 · Cited by 22
The Exosome Journey: From Biogenesis to Regulation and Function in Cancers
Li, Y., Li, M., Li, B., Li, Y., Shen, T., & Zhao, B. (2022) · Journal of Oncology · doi:10.1155/2022/9356807 · Cited by 26
A comprehensive overview of promising biomarkers in stage II colorectal cancer
Parent, P., Cohen, R., Rassy, E., Svrcek, M., Taı̈eb, J., André, T., & Turpin, A. (2020) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2020.102059 · Cited by 22
Extracellular vesicles in cancer pros and cons: The importance of the evidence-based medicine
Cappello, F., & Fais, S. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.01.011 · Cited by 23
Circulating MicroRNAs in Gastrointestinal Cancer
Ohtsuka, M., Iwamoto, K., Naito, A., Imasato, M., Hyuga, S., Nakahara, Y., Mikamori, M., Furukawa, K., Moon, J., Asaoka, T., et al. (2021) · Cancers · doi:10.3390/cancers13133348 · Cited by 21
Wu, L., Xue, M., Lai, S., Chen, J., Lin, Y., Ding, N., Zhong, J., Chen, S., & Wang, L. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121872 · Cited by 21
Xia, B., Liu, Y., Wang, J., Lu, Q., Lv, X., Deng, K., & Yang, J. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106880 · Cited by 21
The potential of liquid biopsies in gastrointestinal cancer
Wu, C., Zhang, J., Li, H., Xu, W., & Zhang, X. (2020) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2020.06.007 · Cited by 21
Exosome-Derived microRNA: Efficacy in Cancer
Padda, J., Khalid, K., Khedr, A., Patel, V., Al-Ewaidat, O. A., Tasnim, F., Padda, S., Cooper, A. C., & Jean-Charles, G. (2021) · Cureus · doi:10.7759/cureus.17441 · Cited by 23
Asadirad, A., Khodadadi, A., Talaiezadeh, A., Shohan, M., Rashno, M. M., & Joudaki, N. (2022) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2022.101831 · Cited by 21
Tumour‐derived exosomes in liver metastasis: A Pandora's box
Li, S., Qu, Y., Liu, L., Wang, C., Li, Y., Bai, H., & Wang, J. (2023) · Cell Proliferation · doi:10.1111/cpr.13452 · Cited by 20
Hao, Y.-J., Yang, C., Chen, M., Chang, L.-W., Lin, C., Lo, L., Huang, S., Lyu, Y.-Y., Jiang, J., & Tseng, F. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11092400 · Cited by 19
Lopez, G., Boggio, F. L., Ferrero, S., Fusco, N., & GOBBO, A. D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103014 · Cited by 18
Spadaccino, F., Gigante, M., Netti, G. S., Rocchetti, M. T., Franzin, R., Gesualdo, L., Castellano, G., Stallone, G., & Ranieri, E. (2021) · Pharmaceuticals · doi:10.3390/ph14040322 · Cited by 18
Metadata
- Authors
- Tsukamoto, M., Iinuma, H., Yagi, T., Matsuda, K., & Hashiguchi, Y.
- Affiliations
- Teikyo University (JP)
- Venue
- Oncology
- Publisher
- S. Karger AG
- Published
- 2017
- Volume
- 92
- Issue
- 6
- Pages
- 360-370
- ISSN
- 0030-2414 (ISSN-L)
- 1423-0232
- OpenAlex
- W2605003516
- Cited by
- 203
- References
- 36
- Citations by year
- 2026: 8 · 2025: 10 · 2024: 11 · 2023: 26 · 2022: 22 · 2021: 42 · 2020: 31 · 2019: 27 · 2018: 20 · 2017: 6
- FWCI
- 9.39
- Type
- journal article
- Language
- en
- Open access
- Licence
- Locations
- Oncology (publishedVersion)
- PubMed (publishedVersion)
- Institutional Repositories DataBase (IRDB) (submittedVersion, cc-by-nc-nd)
- Funders
- Japan Society for the Promotion of Science (17K10608, 15K10150, 17K10655)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Circular RNAs in diseases
- Keywords
- colorectal cancer, circulating exosomes, plasma biomarkers, TNM stage, liver metastasis, prognostic factors, overall survival, disease-free survival, tumor recurrence prediction
- MeSH terms
- Humans, Liver Neoplasms, Neoplasm Recurrence, Local, Neoplasm Staging, Prognosis, Tumor Cells, Cultured, Biomarkers, Tumor, Colorectal Neoplasms, Gene Expression Regulation, Neoplastic, Survival Rate, MicroRNAs, Microarray Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
